Sterling Hospitals recently hosted ‘Hemato-Onco Update 2.0’, an academic conclave focused on advancements in oncosciences, particularly hemato-oncology. The event gathered over 200 leading oncologists and experts to discuss the latest innovations, evidence-based treatments, and future trends in cancer care.

The conference was inaugurated by Dr. Meenakshi, Chief District Health Officer (CDHO), and Dr. Mitesh Shah, President of IMA Vadodara. Renowned oncologists Dr. M.B. Aggarwal and Dr. Purvesh Parikh shared insights on evolving research and treatment strategies. Given the rising incidence of leukemia, lymphoma, and multiple myeloma in India, discussions emphasized the need for advanced diagnostics, targeted therapies, and multidisciplinary collaboration to improve survival rates.

Dr. Simmardeep Singh Gill, CEO of Sterling Hospitals, highlighted the institution’s dedication to integrating the latest breakthroughs into patient care. Dr. Vibha Naik, Director of Medical Oncology, stressed the importance of patient-centric care and empathetic communication, ensuring holistic treatment beyond clinical success.

The event explored CAR T-cell therapy, antibody-drug conjugates, AI-driven cancer diagnostics, and prognostic tools for breast cancer. An inter-college oncology quiz fostered academic engagement among participants.

Sterling Hospitals, recently honored as the Best Oncology Hospital, continues to lead in clinical excellence and innovation, reaffirming its commitment to advancing cancer care.